EMIG Scotland Special Interest Group
The final EMIG Scotland webinar will be held on the 23rd November 2021 and they have a packed agenda!
Welcome and Introductions Leslie Galloway, Chair EMIG
The impact of Covid 19 on NHS Scotland,Liz Preston, Director, Synaptik UK
The role of the Scottish Health Technologies Group (SHTG) in Decision making Ed Clifton, Unit Head, SHTG
Results from the EMIG Scotland member Survey Brenda Dooley, CEO, Axis Consulting Scotland, Managing Secretariat, EMIG Scotland
to include a Q & A session
You can register for the meeting via the EMIG Platform. If you haven’t already registered for the Platform you can enter your email and click reset password to gain access and receive the option of changing your password. If you have any problems please contact jill.payne@emig.org.uk
Biographies of our Speakers
Elizabeth Preston is an experienced healthcare professional with a varied clinical and managerial career in the NHS. She trained at Guy’s Hospital London and subsequently in neurosciences at Addenbrooke’s Hospital, Cambridge. She moved to Edinburgh from Manchester to take up a sister’s post in neurosurgery. She subsequently took up a management position in Neurosciences and from there gained an MBA from Edinburgh Napier University and an MSc in Advanced Leadership Practice from Harvard Business School / Edinburgh Napier University along with a Post Graduate Diploma in Health Economics from the University of Aberdeen.
Elizabeth has managed many services in NHS Lothian, but cancer services remain her passion. She was the Clinical Lead for the TCAT programme in the South East Scotland Cancer Network and has always been passionate about improving services for patients and supporting the staff to undertake change.
She is now a Director of Synaptik, which is a Healthcare Consultancy based in Dunfermline, providing organisational & personal development and coaching, along with supplementary staffing for Health Boards.
Ed Clifton is the Unit Head of the Scottish Health Technologies Group (SHTG). SHTG is a national health technology assessment (HTA) agency that provides evidence support and advice to NHS Scotland on the use of new and existing health technologies which are not medicines and which are likely to have significant implications for people’s care. Prior to his current role, Ed has gained over 10 years of experience working as an economist within NHS Scotland, most recently as a Senior Health Economist within Healthcare Improvement Scotland.
Brenda Dooley, Founder and Chief Executive, AXIS Consulting Ltd., is an expert market access strategist with 20+ years international biopharma industry experience. She established AXIS Consulting in 2012 and with over 80 bespoke reimbursement submissions now completed for the Irish authorities, AXIS Consulting has become the leading global provider of services to pharmaceutical companies seeking access for new medicines in Ireland.
A member of the Minerva International Health Economics Network, Brenda has established strategic links with providers of health economics services across the UK, EU, USA and Canada. Knowing that a customised approach is fundamentally important for successful submissions to national agencies, Brenda has led AXIS Consulting’s recent expansion of market access services to Scotland and BeNeLuxAI.
Brenda holds a BA (Hons) in Business, a Diploma (Hons) in Financial Management and a MSc (Hons) in Health Economics. A member of Ireland’s Institute of Directors, Brenda is also a member of the National University of Ireland, Galway’s Investment committee having previously been a member of the University’s Risk & Audit committee.